Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective, Observational Study of the Progression of Intermediate Age-Related Macular Degeneration

NCT05300724 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT05300724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05300724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective, Observational Study of the Progression of Intermediate Age-Related Macular Degeneration
Lead sponsor
Genentech, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
May 27, 2022
Completion date
June 30, 2027
Enrollment
400 (actual)
Sites
74

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration